Skip to content

SBK Pharma

Active Risk: not assessed
Private limited companyfounded 2022active for 4 yearsRoute de Ster 3, 4970 Stavelot, BelgiumKBO/BCE: BE 0782.437.533

Acts, filings and financial milestones

Deadline for the 2026 accounts: 31-07-2027
2026
16-07
NBB filing Annual accounts 2025 filedNBB
abbreviated format · 15 days before the deadline
2025
31-12
Financial Weakest financial yearnet €8,967 ▼35.7%
The net result drops to €8,967, the lowest from 2023 to 2025.
21-07
NBB filing Annual accounts 2024 filedPDF
full format · 10 days before the deadline
2024
23-07
NBB filing Annual accounts 2023 filedPDF
micro format · 8 days before the deadline
2022
23-02
Gazette deed Incorporation
Founding capital of €6,000, 100 shares · Founder: BECHET Monique Rose Renée Denise · Appointment: BECHET Monique Rose Renée Denise (director)6 points ▸
  • Founder, BECHET Monique Rose Renée Denise
  • Founding capital, €6,000, 100 shares
  • 100 shares
  • Registered office clause, Route de Ster 3, 4970 Stavelot
  • Director appointment, BECHET Monique Rose Renée Denise (director (not named in the articles))
  • Board rule, 1
  • The act holds 11 more points.

Open the act in the Belgian Official Gazette

Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

On 21 February 2022, SBK Pharma was incorporated as a private limited company by one natural person, with a starting capital of €6,000.12 BECHET Monique Rose Renée Denise has served as director since 2022.3 Total assets went from €218,232 in 2023 to €256,504 in 2025.4

  1. 1KBO register
  2. 2Belgian Official Gazette, 23-02-2022
  3. 3National Bank, annual accounts 2025
  4. 4National Bank, annual accounts 2023 and 2025

Next steps